Journal List > J Korean Soc Transplant > v.27(4) > 1034406

Park, Cho, Kim, Kim, Kim, Kim, Cho, Kim, Park, Chung, Choi, Lee, Park, Lee, and Yu: Evaluation of the Korean Network for Organ Sharing Expanded Donor Criteria in Deceased Donor Renal Transplantation

Abstract

Background:

This study was conducted in order to evaluate the propriety of expanded donor criteria in Korea and to identify the preoperative factors influencing allograft survival and function.

Methods:

We studied 404 patients who received deceased renal transplants from five transplantation centers of 2, 3 territory from 2000 to 2010. Differences in 1-year graft function, delayed graft function (DGF) rate, and graft survival rate between the standard criteria donor (SCD) and expanded criteria donor (ECD) were compared retrospectively. The preoperative factors influencing graft function and graft survival were analysed.

Results:

SCD showed significantly better 1-year graft function than ECD (P=0.011). No differences in 1-year acute rejection rate were observed between SCD (13.2%) and ECD (16.9%) (P=0.449). Significantly higher DGF rate was observed for ECD (25.4%) than for SCD (14.1%) (P=0.022). Graft type had no significant influence on 5-year graft survival (SCD 94.5% vs. ECD 93.7%) (P=0.835). Advanced donor age (P=0.001), donor hypertension history (P=0.047), high serum creatinine (P=0.002), and cerebral infarction as cause of death (P=0.004) had a negative influence on 1-year allograft function. Significantly low graft survival was observed for advanced donor age (P=0.002).

Conclusions:

Graft function, DGF rates of ECD were poorer than those of SCD. Graft survival rate of ECD was comparable to that of SCD kidney. Korean Network for Organ Sharing expanded criteria may underestimate the organ quality of deceased kidney and modification may be needed in order to expand the potential donor pool through nationwide study.

REFERENCES

1). Korean Network for Organ Sharing (KONOS). 2012 KONOS Annual Report [Internet]. Seoul: KONOS;2012. [cited 2013 Jul 13]. Available from. http://www.konos.go.kr.
2). Crew RJ, Ratner LE. ABO-incompatible kidney transplantation: current practice and the decade ahead. Curr Opin Organ Transplant. 2010; 15:526–30.
crossref
3). Evenson AR. Utilization of kidneys from donation after circulatory determination of death. Curr Opin Organ Transplant. 2011; 16:385–9.
crossref
4). Schold JD, Segev DL. Increasing the pool of deceased donor organs for kidney transplantation. Nat Rev Nephrol. 2012; 8:325–31.
crossref
5). Tso PL, Dar WA, Henry ML. With respect to elderly patients: finding kidneys in the context of new allocation concepts. Am J Transplant. 2012; 12:1091–8.
crossref
6). Warren DS, Montgomery RA. Incompatible kidney transplantation: lessons from a decade of desensitization and paired kidney exchange. Immunol Res. 2010; 47:257–64.
crossref
7). Zbroch E, Mał yszko J, Myś liwiec M, Przybył owski P, Durlik M. Hypertension in solid organ transplant recipients. Ann Transplant. 2012; 17:100–7.
crossref
8). Ojo AO, Hanson JA, Meier-Kriesche H, Okechukwu CN, Wolfe RA, Leichtman AB, et al. Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol. 2001; 12:589–97.
crossref
9). Rosengard BR, Feng S, Alfrey EJ, Zaroff JG, Emond JC, Henry ML, et al. Report of the Crystal City meeting to maximize the use of organs recovered from the cadaver donor. Am J Transplant. 2002; 2:701–11.
crossref
10). Pascual J, Zamora J, Pirsch JD. A systematic review of kidney transplantation from expanded criteria donors. Am J Kidney Dis. 2008; 52:553–86.
crossref
11). Lai Q, Nudo F, Levi Sandri GB, Melandro F, Ferretti S, Grieco M, et al. Survival after kidney transplantation does not differ with 50-59- or over 60-year-old ex-panded-criteria donors. Transplant Proc. 2011; 43:1030–2.
crossref
12). Karatzas T, Gompou A, Bokos J, Dimitroulis D, Boletis J, Kostakis A, et al. Optimal utilization of expanded criteria deceased donors for kidney transplantation. Int Urol Nephrol. 2011; 43:1211–9.
crossref
13). Kim JM, Kim SJ, Joh JW, Kwon CH, Song S, Shin M, et al. Is it safe to use a kidney from an expanded criteria donor? Transplant Proc. 2011; 43:2359–62.
crossref
14). Park JY, Cho JH, Yoon YD, Song EJ, Jin MK, Yu CH, et al. Outcome of cadaveric kidney transplantation from expanded criteria donors. Korean J Med 2011;8:408-18. (박자용, 조장희, 윤영득, 송은주, 진미경, 류정훈, 등. 확장 범주 뇌사자의 신장이식 성적. 대한내과학회지. 2011; 80:408–18.
15). Metzger RA, Delmonico FL, Feng S, Port FK, Wynn JJ, Merion RM. Expanded criteria donors for kidney transplantation. Am J Transplant. 2003; 3(Suppl 4):114–25.
crossref
16). Kauffman HM, Bennett LE, McBride MA, Ellison MD. The expanded donor. Transplant Rev (Orlando). 1997; 11:165–90.
crossref
17). Nyberg SL, Matas AJ, Kremers WK, Thostenson JD, Larson TS, Prieto M, et al. Improved scoring system to assess adult donors for cadaver renal transplantation. Am J Transplant. 2003; 3:715–21.
crossref
18). Wijnen RM, Booster MH, Stubenitsky BM, de Boer J, Heineman E, Kootstra G. Outcome of transplantation of non-heart-beating donor kidneys. Lancet. 1995; 345:1067–70.
crossref
19). Cohen B, Smits JM, Haase B, Persijn G, Vanrenterghem Y, Frei U. Expanding the donor pool to increase renal transplantation. Nephrol Dial Transplant. 2005; 20:34–41.
crossref
20). Kootstra G, van Heurn E. Non-heartbeating donation of kidneys for transplantation. Nat Clin Pract Nephrol. 2007; 3:154–63.
crossref
21). Kimber RM, Metcalfe MS, White SA, Nicholson ML. Use of non-heart-beating donors in renal transplantation. Postgrad Med J. 2001; 77:681–5.
crossref
22). Kong PS, Lee KW, Choi IS, Kim SJ, Song GD, Lee SK, et al. The analysis of risk factors of donor affecting the graft survival in cadaveric kidney transplantation. J Korean Surg Soc 2001;60:281-7. (공필성, 이광웅, 최인석, 김성주, 송건도, 이석구, 등. 사체신이식에서 이식신생존율에 영향을 미치는 사체공여자의 위험인자 분석. 대한외과학회지. 2001; 60:281–7.

Fig. 1.
Renal allograft survival rate according to donor criteria: standard criteria donor (SCD) versus expanded criteria donor (ECD).
jkstn-27-166f1.tif
Fig. 2.
Influence of donor age on recipient allograft survival.
jkstn-27-166f2.tif
Fig. 3.
Total of 71 patients were assorted as expanded criteria donor (ECD) by Korean Network for Organ Sharing (KONOS) criteria and only 27 patients (38.0%) of them were expanded donor by United Network for Organ Sharing (UNOS) criteria. Abbreviation: SCD, standard criteria donor.
jkstn-27-166f3.tif
Fig. 4.
Kidney grade determined by Nyberg donor score in 71 patients of Korean Network for Organ Sharing expanded criteria donor.
jkstn-27-166f4.tif
Table 1.
Comparison of recipient and donor characteristics
Variable SCD (n=333) ECD (n=71) P-value
Recipient characteristics      
 Age 42.5±10.6 44.7±12.0 0.111
 Male 180 (54.1) 41 (57.7) 0.601
 Duration of dialysis 67.6±41.8 62.6±52.5 0.080
 Body mass index (kg/m2) 22.1±3.3 22.6±3.4 0.231
 Cause of ESRD     0.304
  Diabetes mellitus 27 (8.1) 5 (7.0)  
  Hypertension 82 (24.6) 20 (28.2)  
  Glomerulonephritis 173 (52.0) 41 (57.7)  
  Others 51 (15.3) 5 (7.0)  
 Previous transplant 50 (15.0) 10 (14.1) 0.858
 HLA zero mismatch 21 (6.3) 7 (9.9) 0.303
 No. of HLA mismatches 3.7±1.5 3.9±1.7 0.001
Donor characteristics      
 Age 38.2±13.8 44.8±16.6 <0.001
 Male 226 (67.9) 54 (76.1) 0.203
 History of hypertension 49 (14.7) 19 (26.8) 0.016
 Diabetes mellitus 6 (1.8) 4 (5.6) 0.080
 Cause of death     0.703
  Cerebrovascular accident 289 (86.8) 60 (84.5)  
  Others 44 (13.2) 11 (15.5)  
 Body mass index (kg/m2) 22.2±2.9 22.8±3.1 0.085
 Proteinuria (≥++, 2 times) 0 (0) 11 (15.5) 0.000
 Use of norepinephrine 155 (46.5) 38 (53.5) 0.298

Data are presented as mean±SD or number (%).

Abbreviations: SCD, standard criteria donor; ECD, extended criteria donor; ESRD, end stage renal disease; HLA, human leukocyte antigen.

Table 2.
Causes which assorted deceased donor as expanded criteria donor
Variable ECD (n=71)
Nonheart beating donor 3 (4.2)
Hypotensive attack a 17 (23.9)
Age ≥60 years 16 (22.5)
sCr ≥3.0 mg/dL or CrCl ≤60 mL/min 24 (33.8)
Proteinuria (≥++) ≥2 times 8 (11.3)
Proteinuria (≥++) ≥2 times+sCr ≥3.0 mg/dL 2 (2.8)
Age ≥60 years+sCr ≥3.0 mg/dL 1 (1.4)

Abbreviation: ECD, extended criteria donor.

a Cardiac arrest during donor management.

Table 3.
Comparison of clinical results in terms of estimated glomerular filtration rate, acute resection episode, and delayed graft function between standard criteria donor and expanded criteria donor
Variable SCD (n=333) ECD (n=71) P-value
eGFR at 6 mo 66.5±29.1 57.3±17.1 0.007
eGFR at 1 yr 66.1±27.9 57.3±20.2 0.011
eGFR at 3 yr 64.2±27.4 60.0±29.4 0.202
eGFR at 5 yr 61.8±30.3 63.7±37.4 0.806
Acute rejection within 1 yr 44 (13.2) 12 (16.9) 0.449
Delayed graft function 47 (14.1) 18 (25.4) 0.022

Data are presented as mean±SD or number (%).

Abbreviation: eGFR, estimated glomerular filtration rate calculated by Modification of Diet in Renal Disease equation.

Table 4.
Donor variables associated with recipient estimated glomerular filtration rate at 1 year
Donor variables No. (%) eGFR at 1 year (mL/min/1.73 m2) P-value
Age (yr)     <0.001
 <20 56 (13.9) 79.9±27.3  
 20∼39 110 (27.2) 65.2±29.7  
 40∼59 221 (54.7) 61.5±23.8  
 ≥60 17 (4.2) 49.8±26.9  
Creatinine (mg/dL)     0.030
 <1.5 262 (64.9) 66.7±27.2  
 1.5∼2.9 113 (28.0) 60.6±27.4  
 ≥3.0 29 (7.2) 59.9±18.7  
Proteinuria (≥2++)     0.894
 Present 11 (2.7) 63.7±16.1  
 Absent 393 (97.3) 64.5±27.1  
Cardiac arrest event during donor management     0.266
 Yes 20 (5.0) 59.5±19.5  
 No 384 (95.0) 64.8±27.2  
Hypertension history     0.047
 Yes 68 (6.8) 59.9±26.0  
 No 336 (83.2) 65.5±27.0  
Cause of death     0.004
 CVA 349 (86.4) 63.5±27.7  
 Non-CVA 55 (13.6) 70.9±20.3  
HLA mismatch     0.632
 0 28 (6.9) 63.4±23.2  
 1 9 (2.2) 51.8±16.0  
 2 29 (7.2) 62.6±21.6  
 3 76 (18.8) 67.7±26.6  
 4 122 (30.2) 64.2±26.1  
 5 109 (27.0) 64.7±31.3  
 6 31 (7.7) 63.8±24.6  

Data are presented as mean±SD.

Abbreviations: eGFR, estimated glomerular filtration rate; CVA, cerebrovascular accident; HLA, human leukocyte antigen.

Table 5.
Multivariate regression models for risk factors of 1-year estimated glomerular filtration rate after deceased donor kidney transplantation
Risk factor B SE β T P-value
Donor age          
 20∼39 −13.084 4.428 −0.217 −3.003 0.003
 40∼59 −16.607 4.081 −0.308 −4.069 <0.001
 ≥60 −28.230 7.597 −0.211 −3.716 <0.001
Serum creatinine (mg/dL)          
 1.5∼2.9 −4.548 2.978 −0.076 −1.527 0.127
 ≥3.0 −5.699 5.178 −0.055 −1.100 0.272
History of hypertension −1.253 3.664 −0.017 −0.342 0.733
Cause of death (CVA) −1.253 3.920 −0.032 −0.649 0.517

Adjust R2=0.057; R2=0.073; F=4.480; P=0.000.

Abbreviations: B, unstandardised beta coefficient; SE, standard error; β, standardised beta coefficient; T, t-test statistic; R2, R squared change.

TOOLS
Similar articles